Literature DB >> 4607936

The effect of amphotericin B on Trypanosoma cruzi in vitro and in vivo.

A E Horvath, C H Zierdt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4607936

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


× No keyword cloud information.
  6 in total

1.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors.

Authors:  F S Buckner; J H Griffin; A J Wilson; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  In vitro effects of amphotericin B on growth and ultrastructure of the amoeboflagellates Naegleria gruberi and Naegleria fowleri.

Authors:  F L Schuster; E Rechthand
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

4.  Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.

Authors:  F S Buckner; C L Verlinde; A C La Flamme; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.

Authors:  Sabrina Cencig; Nicolas Coltel; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

6.  Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.

Authors:  Joseph D Planer; Matthew A Hulverson; Jennifer A Arif; Ranae M Ranade; Robert Don; Frederick S Buckner
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.